In the present study, Corynoxine was found to suppress the ability of LUAD cells to proliferate, migrate, and engage in invasivity at least in part by suppressing PI3K/AKT pathway activity and the expression of COX-2, thereby interfering with the progression of this deadly form of cancer. The gene discussed is AKT1; the disease is cancer.